119 related articles for article (PubMed ID: 37925318)
1. Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C.
Kaur R; Gonzalez E; Pham M; Pichichero M
Vaccine; 2023 Nov; 41(48):7265-7273. PubMed ID: 37925318
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Hao L; Kuttel MM; Ravenscroft N; Thompson A; Prasad AK; Gangolli S; Tan C; Cooper D; Watson W; Liberator P; Pride MW; Jansen KU; Anderson AS; Scully IL
Vaccine; 2022 Aug; 40(33):4872-4880. PubMed ID: 35810060
[TBL] [Abstract][Full Text] [Related]
3. The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.
Spencer BL; Shenoy AT; Orihuela CJ; Nahm MH
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637806
[TBL] [Abstract][Full Text] [Related]
4. Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization.
Juergens C; Patterson S; Trammel J; Greenberg D; Givon-Lavi N; Cooper D; Gurtman A; Gruber WC; Scott DA; Dagan R
Clin Vaccine Immunol; 2014 Sep; 21(9):1277-81. PubMed ID: 24990907
[TBL] [Abstract][Full Text] [Related]
5. Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea.
Choe YJ; Lee HJ; Lee H; Oh CE; Cho EY; Choi JH; Kang HM; Yoon IA; Jung HJ; Choi EH
Vaccine; 2016 Sep; 34(40):4771-6. PubMed ID: 27546875
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N
J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777
[TBL] [Abstract][Full Text] [Related]
7. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.
Cooper D; Yu X; Sidhu M; Nahm MH; Fernsten P; Jansen KU
Vaccine; 2011 Sep; 29(41):7207-11. PubMed ID: 21689707
[TBL] [Abstract][Full Text] [Related]
8. Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.
Rajam G; Carlone GM; Romero-Steiner S
Clin Vaccine Immunol; 2007 Sep; 14(9):1223-7. PubMed ID: 17609392
[TBL] [Abstract][Full Text] [Related]
9. Humoral response to a 13-valent pneumococcal conjugate vaccine in kidney transplant recipients.
Oesterreich S; Lindemann M; Goldblatt D; Horn PA; Wilde B; Witzke O
Vaccine; 2020 Apr; 38(17):3339-3350. PubMed ID: 32178906
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children.
Kaur R; Pham M; Pichichero M
Vaccine; 2021 Jun; 39(29):3900-3906. PubMed ID: 34116872
[TBL] [Abstract][Full Text] [Related]
11. The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Shi Y; Nolan KM; Burton RL; Shekar T; Murphy RD; Banniettis N; Musey L; Buchwald UK
Hum Vaccin Immunother; 2023 Aug; 19(2):2235238. PubMed ID: 37529944
[TBL] [Abstract][Full Text] [Related]
12. Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine.
Kaur R; Pichichero M
Vaccine; 2020 Jun; 38(28):4423-4431. PubMed ID: 32402752
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse models.
Curry S; Kaufhold RM; Monslow MA; Zhang Y; McGuinness D; Kim E; Nawrocki DK; McHugh PM; Briggs ML; Smith WJ; He J; Joyce JG; Skinner JM
Vaccine; 2023 Jan; 41(4):903-913. PubMed ID: 36566163
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model.
Fuji N; Pichichero M; Kaur R
Vaccine; 2022 Oct; 40(44):6412-6421. PubMed ID: 36192274
[TBL] [Abstract][Full Text] [Related]
15. Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children.
Ryman J; Sachs JR; Yee KL; Banniettis N; Weaver J; Weiss T
Expert Rev Vaccines; 2024; 23(1):60-68. PubMed ID: 38073483
[TBL] [Abstract][Full Text] [Related]
16. Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
Hurley D; Griffin C; Young M; Scott DA; Pride MW; Scully IL; Ginis J; Severs J; Jansen KU; Gruber WC; Watson W
Clin Infect Dis; 2021 Oct; 73(7):e1489-e1497. PubMed ID: 32716500
[TBL] [Abstract][Full Text] [Related]
17. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
Simell B; Nurkka A; Ekström N; Givon-Lavi N; Käyhty H; Dagan R
Clin Vaccine Immunol; 2012 Oct; 19(10):1618-23. PubMed ID: 22875604
[TBL] [Abstract][Full Text] [Related]
18. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
19. Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections.
Hare KM; Smith-Vaughan HC; Chang AB; Pizzutto S; Petsky HL; McCallum GB; Leach AJ
Vaccine; 2017 Feb; 35(5):747-756. PubMed ID: 28062125
[TBL] [Abstract][Full Text] [Related]
20. Creation, characterization, and assignment of opsonic values for a new pneumococcal OPA calibration serum panel (Ewha QC sera panel A) for 13 serotypes.
Burton RL; Kim HW; Lee S; Kim H; Seok JH; Lee SH; Balloch A; Licciardi P; Marimla R; Bae S; Nahm MH; Kim KH
Medicine (Baltimore); 2018 Apr; 97(17):e0567. PubMed ID: 29703046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
